References
- IARC. Di (2-ethylhexyl) phthalate. IARC Monographs on the Evaluation of Car-cinogenic Risks to Humans. 2000; 77: 41–148.
- Huff J. IARC Monographs, Industry influence, and upgrading, downgrad-ing, and under-grading chemicals: a personal point of view. Int J Occup Env-iron Health. 2002; 8: 249–70.
- Park RM, Mirer FE. A survey of mortal-ity at two automotive engine manufac-turing plants. Am J Ind Med. 1996; 30: 664–73.
- Park RM, Wegrnan DH, Silverstein MA, Maizlish NA, Mirer FE. Causes of death among workers in a ball bearing manu-facturing plant. Am J Ind Med. 1988; 13: 569–80.
- Silverstein M, Park R, Marmor M, Mai-zlish N, Mirer F. Mortality among bear-ing plant workers exposed to metal-working fluids and abrasives. J Occup Med. 1988; 30: 706–14.
- Kluwe WM, McConnell EE, Huff JE, Haseman JK, Douglas JF, Hartwell WV. Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. Environ Health Perspect. 1982; 45: 129–33.
- Huff JE, Kluwe WM. Phthalate esters carcinogenicity in F344/N rats and B6C3F1 mice. Progr Clin Biol Res. 1984; 141: 137–54.
- IARC. Peroxisome Proliferation and its Role in Carcinogenesis. IARC Techni-cal Report No. 24. 1995.
- Melnick RL. The IARC Evaluation of Di(2-ethylhexyl)phthalate: a flawed decision based on an untested hypoth-esis. Intl Occup Environ Health. 2002; 8: 284–86.
- Borghoff WJ, Lehman-McKeeman LD, Short BC, Hard GC, Swenberg JA. Cri-tique of RL Melnick's “An alternative hypothesis on the role of chemically induced protein droplet (alpha 2u-globulin) nephropathy in renal car-cinogenesis. Regal Toxicol Pharmacol. 1993;18:35/-64.
- Hard GC. Significance of the renal effects of ethyl benzene in rodents for assessing human carcinogenic risk. Toxicol Sci. 2002; 69: 3041.
- Doull J, Cattley R, Elcombe C, et al. A cancer risk assessment of di(2-ethyl-hexyl) phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Regal Toxicol Pharmacol. 1999; 29: 327–57.
- Popp JA, Garvey LK, Cattley RC. In vivo studies on the mechanism of di (2-ethyl-hexyflphthalate carcinogenesis. Toxi-col Ind Health. 1987; 3: 151–63.
- Borghoff SJ, Short BC, Swenberg JA. Biochemical mechanisms and pathobi-ology of alpha 2u-globulin nephropa-thy. Annu Rev Pharmacol Toxicol. 1990; 30: 349–67.
- Lehman-McKeeman LD, Gamsky EA. Choline supplementation inhibits diethanolamine-induced morphologi-cal transformation in Syrian hamster embryo cells: evidence for a carcino-genic mechanism. Toxicol Sci. 2000; 55: 303–10.
- Lehman-McKeernan LD, Gamsk EA, Hicks SM, Vassallo JD, Mar MH, Zeisel SH. Diethanolamine induces hepatic choline deficiency in mice. Toxicol Sci. 2002; 67: 38–45.
- David RM, Moore MR, Cifone MA, Finney DC, Guest D. Chronic peroxi-some proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di (2-e thylhexyl) phthalate and the effects of recovery. Toxicol Sci. 1999; 50: 195–205.
- David RM, Moore MR, Finney DC, Guest D. Chronic toxicity of di (2-ethyl-hercyl)phthalate in mice. Toxicol Sci. 2000; 58: 377–85.
- DavidR M, Moore MR, Finney DC, Guest D. Chronic toxicity of di (2-ethyl-hexyl)phthalate in rats. Toxicol Sci. 2000; 55: 433–43.